Webinar: Dr Danielle Bitterman & Dr Subha Perni - The role of AI in clinical trials

Click here to register

With rapid increase in the use of artificial intelligence in healthcare, the need for thoughtful, ethical, and impactful application to support clinical trials is imperative. This webinar will explore the current and future applications of artificial intelligence for clinical trial design, conduct, and reporting, with a focus on the ethical considerations of these new technologies.

Dr Danielle Bitterman is an Assistant Professor in the Department of Radiation Oncology at Brigham and Women’s Hospital/Dana-Farber Cancer Institute, Harvard Medical School. Dr. Bitterman is a physician-scientist whose expertise is in artificial intelligence and natural language processing. Her research is focused on improving data driven cancer care and her laboratory develops natural language processing methods that process high volumes of data from electronic health records to inform care and facilitate communication.

Dr. Subha Perni is an Assistant Professor in the Department of Radiation Oncology at MD Anderson Cancer Center. Dr. Perni specializes in the care of patients with central nervous system malignancies. Her research focuses on designing prospective patient-centered clinical trials incorporating advanced technology and imaging with the aim of improving quality of life and outcomes for these patients. She has additional expertise in ethics and decision-making.